CAS 103342-82-1

2H-1,4-Benzodiazepin-2-one,5-(2-fluorophenyl)-1,3-dihydro-3-(1H-indol-3-ylmethyl)-1-methyl-, (3R)-

Description:

2H-1,4-Benzodiazepin-2-one, 5-(2-fluorophenyl)-1,3-dihydro-3-(1H-indol-3-ylmethyl)-1-methyl-, (3R)-, identified by CAS number 103342-82-1, is a complex organic compound characterized by its benzodiazepine core structure, which is known for its psychoactive properties. This compound features a fluorophenyl substituent, which may influence its pharmacological activity and lipophilicity. The presence of the indole moiety suggests potential interactions with biological targets, particularly in the central nervous system. The stereochemistry indicated by the (3R) designation implies specific spatial arrangements of atoms that can significantly affect the compound's biological activity and receptor binding affinity. As a member of the benzodiazepine family, it may exhibit properties such as anxiolytic, sedative, or anticonvulsant effects, although specific biological activities would depend on further empirical studies. Its synthesis and characterization would typically involve advanced organic chemistry techniques, including NMR spectroscopy and mass spectrometry, to confirm its structure and purity.

Formula: C₂₅H₂₀FN₃O

Synonyms:

• 2H-1,4-Benzodiazepin-2-one,5-(2-fluorophenyl)-1,3-dihydro-3-(1H-indol-3-ylmethyl)-1-methyl-, (R)-
• L364373
• R-L 3

L-364,373

CAS: 103342-82-1

KV7.1 (KCNQ1) channel activator

Formula: C₂₅H₂₀FN₃O

Color and Shape: Solid

Molecular weight: 397.44

Ref: TM-T22894

L-364373

CAS: 103342-82-1

Formula: C₂₅H₂₀FN₃O

Molecular weight: 397.45

Ref: 4Z-L-189001

L-364373

Controlled Product

CAS: 103342-82-1

Formula: C₂₅H₂₀FN₃O

Color and Shape: Neat

Molecular weight: 397.444

Ref: TR-L300005

(3R)-5-(2-Fluorophenyl)-3-(1H-Indol-3-Ylmethyl)-1-Methyl-1,3-Dihydro-2H-1,4-Benzodiazepin-2-One

Controlled Product

CAS: 103342-82-1

(3R)-5-(2-Fluorophenyl)-3-(1H-Indol-3-Ylmethyl)-1-Methyl-1,3-Dihydro-2H-1,4-Benzodiazepin-2-One is a benzodiazepine derivative that has been shown to modulate cardiac function in vitro and in vivo. It has a constant expression pattern across diverse tissues and species. (3R)-5-(2-Fluorophenyl)-3-(1H-Indol-3-Ylmethyl)-1-Methyl-1,3 -Dihydro--2H--1,4--Benzodiazepin--2--One has been shown to activate cardiac tissue in vitro and in vivo. This compound also increases the contractility of ventricular myocytes and antagonizes the effects of beta adrenergic receptor agonists on the heart.

Formula: C₂₅H₂₀FN₃O

Purity: Min. 95%

Molecular weight: 397.44 g/mol

Ref: 3D-FF102115